Li, L., Ye, Y., Galimard, J.-E., Labopin, M., Wu, D., Chen, J., Kröger, N., Passweg, J., Salmenniemi, U., Itäla-Remes, M., Poiré, X., Eder, M., Maertens, J., Burns, D., Sengeloev, H., Olesen, G., Blaise, D., Finke, J., Gadisseur, A., Bazarbachi, A., Brissot, E., Nagler, A., Luo, Y., Shi, J., Mohty, M., Huang, H., Ciceri, F. and Claude Gorin Sr., N. (2025) “<i>TET2</i> mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i&gt; haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation”, Haematologica. Pavia, Italy, 110(12), pp. 3088-3093. doi: 10.3324/haematol.2025.287326.